Actions and Detail Panel
Biomedical Commercialisation: Connecting talent in industry and academia
Mon. 7 November 2016, 5:00 pm – 7:30 pm AEDT
Creating communities to drive biomedical commercialisation: connecting talent in industry and academia
An expert panel discussion on fostering academia-industry networks, the importance of diversity in skills, culture and gender diversity, and partnering with pharmaceutical companies. A catered networking session will follow.
Melanie Thompson – General Manager of Education, Skills and Events, MTP Connect
Alfredo Martinez-Coll – General Manager, Stakeholder Engagement, MTP Connect
Kathy Connell – Director, New Ventures ANZ, Johnson & Johnson California Innovation Centre
Kathy is Director of New Ventures, Australia and New Zealand (ANZ) for Johnson & Johnson Innovation, Asia-Pacific and is responsible for implementing our strategy across Australia and New Zealand. Kathy has a clinical background and started her commercial career as the VP of Global Business Development for an Australian biotechnology company. Prior to joining Janssen, Kathy worked for Sanofi engaged in in-licensing late stage pharmaceutical assets. Kathy joined Janssen as Biotechnology Alliance Manager in 2011. Kathy is a registered psychologist and holds Post Graduate Diplomas in Health and Medical Law from the University of Melbourne, Psychology from Monash University and Bachelor degrees in Psychology (Swinburne University) and Applied Science from LaTrobe University. She is based in Sydney Australia.
Darren Kelly – CEO and Managing Director, Occurx Pty Ltd – Brandon Capital Partners
Darren has more than 25 years of management and research experience in the life sciences sector, particularly relating to drug development. He is Associate Dean (Innovation and Commercialisation), Professor and Director of Biomedical Research in the Department of Medicine at The University of Melbourne, St Vincent’s Hospital Melbourne, and an Entrepreneur in Residence with Brandon Capital. He was a Founder, CEO and Director of Fibrotech Therapeutics, a company developing orally active anti-fibrotic inhibitors to treat underlying pathological fibrosis in kidney and heart failure. Fibrotech was sold to Shire Plc for a record $75m USD upfront including milestone payments up to $560m USD. He has published widely in pre-clinical novel interventions and in developing experimental models of cardiovascular disease. Darren was awarded the prestigious TJ Neale Award in 2009 for outstanding contributions to nephrology. He was also awarded best R&D company and best bioctehnology company deal 2014. Darren is a member of the Australian Institute of Company Directors, Ausbiotech, BioMelbourne network and a Fellow of the American Society of Nephrology.
Darren Saunders – UNSW cancer researcher
Dr Darren Saunders is a cancer biologist at UNSW and visiting fellow at the Kinghorn Cancer Centre, Garvan Institute. He was a founding member and deputy chair of the Australian Academy of Science Early-Mid Career Researcher Forum, awarded an Australian Leadership Award (2012) and a NSW Life Scientist Research Award (2010), and has held fellowships from the US Dept of Defense and Cancer Institute NSW. Darren’s research focuses on two key cellular stress adaptation mechanisms in cancer and neurodegeneration: maintenance of proteostasis via the Ubiquitin Proteasome System, and metabolic reprogramming. His work integrates various platforms to better understand genotype-phenotype relationships including proteomics, genomics, and metabolomics and developing creative technology-based approaches to visualizing and communicating complex data. Darren is an active science communicator, makes regular radio and TV appearances, and contributions to print and online media.
Michelle Miller – Biotron Managing Director
Dr Michelle Miller has spent over 20 years in the bioscience industry, with extensive experience in commercial development of early to mid stage technologies. She completed her PhD in the Faculty of Medicine at Sydney University investigating molecular models of oncogene-mediated cancer development. Her experience includes several years at Johnson and Johnson developing anti-HIV gene therapeutics through preclinical research to clinical trials. In 1999 she moved into the finance industry as an Investment Manager with a specialist bioscience venture capital fund, and undertook studies at the Securities Institute of Australia. She has been CEO and Managing Director of Biotron since early 2002.
Martijn Bijker – From Science to Pharma
Martijn Bijker is founder of the company “from SCIENCE to PHARMA” – the first online Medical Science Liaison (MSL) training company for professionals who want to move into a MSL role, but do not have any MSL experience.
Sheila Donnelly – Helmedix | University of Technology Sydney
A Senior lecturer within the University of Technology, Sydney (UTS) Faculty of Science, Sheila is course co-ordinator of Biotechnology and a member of the iThree Institute. Her research led to the discovery of a protein secreted by helminth parasites that modulates cells of the innate immune system, specifically, activating macrophages towards an alternative phenotype which has downstream effects on the host T cell response. At UTS Sheila’s research aims to understand the mechanisms by which helminth parasites successfully manipulate their host’s immune system; and to develop novel therapeutics for the treatment of autoimmune disease. Sheila has published widely and more recently been involved in commercialisation of her research findings in the areas of human health.
About the MCIC
The Michael Crouch Innovation Centre is an emergent force fostering innovation to create a better world. We offer state of the art facilities, including Event Space, Design Space, Maker Space, Exhibit Space and “in-Residence” Co-Working Space. If we can’t help you find a better way, we will help you find someone or something that will. The MCIC aspires to be the leading university-based innovation network in Asia-Pacific by 2025. Read the latest MCIC news. Join our #innovation conversations on Facebook, Twitter, Instagram and Youtube.
Directions: Enter via gate 2 on High Street, Kensington.
Public transport + parking options:http://www.facilities.unsw.edu.au/getting-uni